Sign In
Buy RDY
$13.02
-0.0100 (-0.0767%)
At Close: Jun 03, 2026
Dr Reddy's Laboratories Ltd (RDY) Q3 2024 Earnings Call Transcript
03:50pm, Tuesday, 30'th Jan 2024
Dr Reddy's Laboratories Ltd (RDY) Q3 2024 Earnings Call Transcript
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
11:36am, Thursday, 25'th Jan 2024
With the ease in inflationary pressure, the Zacks Medical - Generic Drugs industry is expected to benefit from declining costs. New product launches provide some respite to AMPH, RDY and TEVA.
Here's Why Doctor Reddy's (RDY) is a Strong Growth Stock
11:22am, Monday, 08'th Jan 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
How to Identify Stock Market Winners Early in 2024
12:01pm, Wednesday, 03'rd Jan 2024
With every year comes a different market theme.
Dr. Reddy's Announces the Acquisition of MenoLabs®, a Leading Women's Health and Dietary Supplements Portfolio of Brands
06:00am, Wednesday, 03'rd Jan 2024
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)---- $RDY #AmyrisInc--Dr. Reddy's announces the acquisition of MenoLabs®, a leading women's health and dietary supplements portfolio of brands.
Dr. Reddy's becomes first Indian pharma company to debut on the Dow Jones Sustainability World Index
07:49am, Thursday, 14'th Dec 2023
HYDERABAD, India--(BUSINESS WIRE)---- $RDY #DJSIWorld--Dr. Reddy's has won back-to-back global recognitions for its commitment and progress on sustainability and Environment Social and Governance agen
Here's Why Doctor Reddy's (RDY) is a Strong Momentum Stock
11:17am, Friday, 08'th Dec 2023
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Dr. Reddy's (RDY), COYA Ink Deal to Develop COYA 302 for ALS
09:02am, Thursday, 07'th Dec 2023
Dr. Reddy's (RDY) enters into a licensing agreement with Coya Therapeutics to develop and commercialize the latter's ALS investigational combination therapy, COYA 302.
India's Dr. Reddy's R&D centre being inspected by US FDA
04:41am, Tuesday, 05'th Dec 2023
India's Dr Reddy's on Tuesday said that its research and development centre in Hyderabad is being inspected by the U.S. Food and Drug Administration.
2 overlooked stocks that crushed earnings but traded lower
06:22am, Monday, 20'th Nov 2023
As the third quarter 2023 earnings season ends, it's worth looking back to see which stocks may have been overlooked or mispriced on their results. Regardless of sector or industry, every earnings sea
Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
11:26am, Thursday, 02'nd Nov 2023
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
11:17am, Monday, 30'th Oct 2023
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to RDY, AMPH and SLGL.
Dr. Reddy's (RDY) Q2 Earnings and Revenues Beat Estimates
09:01am, Monday, 30'th Oct 2023
Dr. Reddy's (RDY) reports better-than-expected fiscal second-quarter 2024 results where both earnings and revenues beat estimates, driven by growth in core businesses in North America and Europe.
Dr Reddy's Laboratories Ltd (RDY) Q2 2024 Earnings Call Transcript
02:48pm, Friday, 27'th Oct 2023
Dr Reddy's Laboratories Ltd (NYSE:RDY ) Q2 2024 Earnings Conference Call October 27, 2023 10:00 AM ET Company Participants Richa Periwal - IR Parag Agarwal - CFO Erez Israeli - CEO Conference Call Par
All You Need to Know About Doctor Reddy's (RDY) Rating Upgrade to Strong Buy
01:32pm, Thursday, 26'th Oct 2023
Doctor Reddy's (RDY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
